|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
OTC Regulation: Latest Developments and Best Practices
There’s pending OTC monograph legislation in Congress that could result in significant changes in the OTC space. And, the FDA issued draft guidance on OTC innovation in 2018.
Christine Kirk — an associate in the Food and Drug Group of Arnall Golden Gregory’s healthcare practice — will discuss recent developments in OTC regulation and enforcement as well as key compliance topics. You’ll learn about:
You’ll come away with a deeper understanding of the recent developments in the OTC area.
Christine Kirk is an associate in the Food and Drug Group within Arnall Golden Gregory’s Healthcare Practice, and focuses her regulatory compliance practice on food, drug, and device law. Ms. Kirk has several years of experience with FDA, where she worked in CDER’s Office of Regulatory Policy (ORP). While at FDA, Ms. Kirk worked on a wide variety of matters, including regulations, guidance, citizen petitions, and policy development. Ms. Kirk also has experience in reviewing comments on proposed regulations and guidance.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing